NFKB1 and diabetic retinopathy: Pae inhibits MMP-9 expression and the inflammatory response in hyperglycemia-induced retinal microglia via inhibition of the TLR4/NF-κB signaling pathway, through the upregulation of suppressor of cytokine signaling 3 in diabetic retinopathy [25].